Join our 20.000 subscribers and receive the monthly newsletter for free!

RELATED ARTICLES
Grail: A billion-dollar gamble?

Grail has vowed to change the field of cancer diagnostics via simple blood tests and ctDNA analysis. Their Big Data approach, in which the company…


All in on cancer immunotherapy

Founded in 2011, iTeos Therapeutics began its activities at the end of 2012. Active in the field of cancer immunotherapy, the company develops inn…


The Fournier-Majoie Foundation: guiding cancer research to clinical application

At 77 years of age, Bernard Majoie is as active as ever. As founder of the Fournier-Majoie Foundation, he dedicates his time to the battle against…

POPULAR TAGS

“Give Life a Chance”: new research fund for neuroendocrine tumors

Written by DS on in the category news with the tags , .


The University of Hasselt, the Jessa Hospital and the East Limburg Hospital will conduct research on neuroendocrine tumors (NET), a rare and aggressive form of cancer, with help from “Give Life a Chance”. The research project is an initiative of NET patient Jan Van Manshoven. He founded “Give Life a Chance” to obtain funds for this research. The organization offered a symbolic check of 15.000 euros to the research institutes.

Every year, an average of 300 patients in Belgium are told that they are suffering from neuroendocrine tumors. This rare form of cancer grows rapidly and can result in metastases in the entire body. It was the wish of Jan Van Manshoven -who died from the disease in February 2015- to get more insight into these type of tumors. He founded “Give Life a Chance” to raise funds for scientific research. The research team -which consists of doctors-professors of the three partners- will focus initially on accelerating the diagnosis.

Read more about: , .

RELATED ARTICLES
Grail: A billion-dollar gamble?

Grail has vowed to change the field of cancer diagnostics via simple blood tests and ctDNA analysis. Their Big Data approach, in which the company…


All in on cancer immunotherapy

Founded in 2011, iTeos Therapeutics began its activities at the end of 2012. Active in the field of cancer immunotherapy, the company develops inn…


The Fournier-Majoie Foundation: guiding cancer research to clinical application

At 77 years of age, Bernard Majoie is as active as ever. As founder of the Fournier-Majoie Foundation, he dedicates his time to the battle against…

POPULAR TAGS

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

GSK Itera Life Science V-Bio Ventures Biowin Turnstone KU Leuven Janssen Flanders.bio XpandInnovation UGent

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.